Come up with a name for your new list and we'll add to it:
NeuroMolecular Pharmaceuticals raised a round of funding on August 22, 2006. Investors include
Mohr Davidow Ventures.
NeuroMolecular Pharmaceuticals is developing and commercializing superior neuroprotective medicines for the treatment of central nervous system (CNS) disorders. The Company has built a robust pipeline…